Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 24 July 2005. doi:10.1136/gut.2005.069633
Gut 2006;55:90-97
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
gut.2005.069633v1
55/1/90    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Novo, E
Right arrow Articles by Parola, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Novo, E
Right arrow Articles by Parola, M

LIVER

Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells

E Novo1, F Marra2, E Zamara1, L Valfrè di Bonzo1, A Caligiuri2, S Cannito1, C Antonaci1, S Colombatto1, M Pinzani2, M Parola1

1 Dip Medicina e Oncologia Sperimentale, University of Torino, Torino, Italy
2 Dip Medicina Interna-Centro di Ricerca, Trasferimento e Alta Formazione "DENOTHE", University of Florence, Florence, Italy

Correspondence to:
Correspondence to:
Professor M Parola
Università degli Studi di Torino, Dip Medicina e Oncologia Sperimentale, C so Raffaello 30, 10125 Torino, Italy; maurizio.parola{at}unito.it

Background and aim: Activated myofibroblast-like cells, originating from hepatic stellate cells (HSC/MFs) or other cellular sources, play a key profibrogenic role in chronic liver diseases (CLDs) that, as suggested by studies in animal models or rat HSC/MFs, may be modulated by reactive oxygen intermediates (ROI). In this study, human HSC/MFs, exposed to different levels of superoxide anion (O2•–) and, for comparison, hydrogen peroxide (H2O2), were analysed in terms of cytotoxicity, proliferative response, and migration.

Methods: Cultured human HSC/MFs were exposed to controlled O2•– generation by hypoxanthine/xanthine oxidase systems or to a range of H2O2 concentrations. Induction of cell death, proliferation, and migration were investigated using morphology, molecular biology, and biochemical techniques.

Results: Human HSC/MFs were shown to be extremely resistant to induction of cell death by O2•– and only high rates of O2•– generation induced either necrotic or apoptotic cell death. Non-cytotoxic low levels of O2•–, able to upregulate procollagen type I expression (but not tissue inhibitor of metalloproteinase 1 and 2), stimulated migration of human HSC/MFs in a Ras/extracellular regulated kinase (ERK) dependent, antioxidant sensitive way, without affecting basal or platelet derived growth factor (PDGF) stimulated cell proliferation. Non-cytotoxic levels of H2O2 did not affect Ras/ERK or proliferative response. A high rate of O2•– generation or elevated levels of H2O2 induced cytoskeletal alterations, block in motility, and inhibition of PDGF dependent DNA synthesis.

Conclusions: Low non-cytotoxic levels of extracellularly generated O2•– may stimulate selected profibrogenic responses in human HSC/MFs without affecting proliferation.


Abbreviations: CLDs, chronic liver diseases; ECM, extracellular matrix; MFs, myofibroblast-like cells; HSC, hepatic stellate cells; HSC/MFs, activated hepatic stellate cells in myofibroblast-like phenotype; ROI, reactive oxygen intermediates; O2•–, superoxide anion; H2O2, hydrogen peroxide; HNE, 4-hydroxynonenal; TIMP, tissue inhibitor of metalloproteinases; PDGF, platelet derived growth factor; TGF-ß1, transforming growth factor ß1; ECL, enhanced chemiluminescence; SFI medium, serum free Iscove’s medium; NO, nitric oxide; L-NAME, N{omega}-nitro-L-arginine methyl ester; LDH, lactate dehydrogenase; X/XO, hypoxanthine/xanthine oxidase system generating superoxide anion; SOD, superoxide dismutase; ERK, extracellular regulated kinase; PI-3 K, phosphatidyl inositol 3-kinase

Keywords: activated human hepatic stellate cells; liver fibrosis; superoxide anion; myofibroblast migration; induction of cell death




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Rehman, V. K. Ramshesh, T. P. Theruvath, I. Kim, R. T. Currin, S. Giri, J. J. Lemasters, and Z. Zhong
NIM811 (N-Methyl-4-isoleucine Cyclosporine), a Mitochondrial Permeability Transition Inhibitor, Attenuates Cholestatic Liver Injury but Not Fibrosis in Mice
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 699 - 706.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. Cannito, E. Novo, A. Compagnone, L. Valfre di Bonzo, C. Busletta, E. Zamara, C. Paternostro, D. Povero, A. Bandino, F. Bozzo, et al.
Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells
Carcinogenesis, December 1, 2008; 29(12): 2267 - 2278.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
L V. di Bonzo, I Ferrero, C Cravanzola, K Mareschi, D Rustichell, E Novo, F Sanavio, S Cannito, E Zamara, M Bertero, et al.
Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential
Gut, February 1, 2008; 57(2): 223 - 231.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. L. Friedman
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
Physiol Rev, January 1, 2008; 88(1): 125 - 172.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. Novo, S. Cannito, E. Zamara, L. V. di Bonzo, A. Caligiuri, C. Cravanzola, A. Compagnone, S. Colombatto, F. Marra, M. Pinzani, et al.
Proangiogenic Cytokines as Hypoxia-Dependent Factors Stimulating Migration of Human Hepatic Stellate Cells
Am. J. Pathol., June 1, 2007; 170(6): 1942 - 1953.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2006 BMJ Publishing Group Ltd & British Society of Gastroenterology